Drugdiscovery >> Pharmaceutical Companies >> News
4045
Views
AstraZeneca and Pfizer merger: Do cancer patients loose? - drugdiscovery.com
AstraZeneca and Pfizer merger: Do cancer patients loose? - drugdiscovery.com


Even the most-sold drug of Pfizer was an aquisition. therefore, expert predict that the company can only survive if it merges with others.
Read More >>


Tags: pfizer, astrazeneca, pfizer merge, astra zeneca aquisition - May 1, 2014
Related Articles
4073
Views
The price of AstraZeneca 's stock increased after Pfizer's offer The price of AstraZeneca 's stock increased after Pfizer's offer
The price of AstraZeneca stocks runned up after Pfizer announced that it is willing to buy o buy the company for around $100 billion. Lately, AstraZeneca turned down another similar offer. Read More >>

Tags: Stock, pharmaceutival business, pharmaceutical companies, AstraZeneca,Pfizer, pharmaceutical stock exchange, pharma stocks, astrazeneca sold

4881
Views
What is happening with AstraZeneca. What is happening with AstraZeneca.
Pfizer announced to buy AstraZeneca many times. But what is in the backround of this diecision and what is happening with the two companies? Read More >>

Tags: Astra Zeneca, Pfizer, pharmaceutical companies, astraZeneca business.

4079
Views
AstraZeneca links with privately held company to research cancer AstraZeneca links with privately held company to research cancer
AstraZeneca has announced that its biologic development arm is going to co-operate with Immunocore Limited. This is a privately held company and works on T-cell related researches. Read More >>

Tags: T-cell, AstraZeneca, Immunocore, co-operation

2923
Views
AstraZeneca buys anti-diabetes giant AstraZeneca buys anti-diabetes giant
AstraZeneca PLC will buy out Bristol-Myers Squibb. This opens a new market for the anglo-swedish company to sell drugs. According to the company this helps to make diabetes drugs free and good Read More >>

Tags: AstraZeneca,Birstol Myers Squibb, diabeters

1516
Views
AstraZeneca CFO to join BG AstraZeneca CFO to join BG
Simon Lowth, chief financial officer at AstraZeneca, is leaving the pharmaceutical company to take on the same role at oil and gas group BG. Read More >>

Tags: AstraZeneca,Simon Lowth

6317
Views
Merck, AstraZeneca ovarian cancer drug deal Merck, AstraZeneca ovarian cancer drug deal
AstraZeneca will take over from Merck the clinical development of a potential ovarian cancer treatment , MK-1775, which is in mid-stage clinical testing as a possible oral treatment for certain form Read More >>

Tags: Merck, AstraZeneca, deal, ovarian cancer, drug, development

4924
Views
AstraZeneca: New Partnership in Combat Kidney Disease AstraZeneca: New Partnership in Combat Kidney Disease
Evotec AG and AstraZeneca step into fellowship to fight kidney disease. The two giants are working on finding new possibilities and components, which might modify disease and help the quick recovery o Read More >>

Tags: contrect, Evotec AG, AstraZeneca, kidney

6706
Views
Pfizer- The world's largest research-based pharmaceutical company Pfizer- The world's largest research-based pharmaceutical company
At Pfizer, science and global resources are applied in order to improve health and well-being at every stage of life. Read More >>

Tags: pfizer, pharmaceutical company

4299
Views
A collaboration between Sanford-Burnham and Pfizer A collaboration between Sanford-Burnham and Pfizer
Sanford-Burnham Medical Research Institute (Sanford-Burnham) has entered into a collaboration with Pfizer Inc. with the aim of identifying new therapeutic targets and strategies for preventing and tre Read More >>

Tags: Sanford-Burnham, Pfizer, colaboration, insulin resistance

4627
Views
AstraZeneca pleased with quarter despite profits fall AstraZeneca pleased with quarter despite profits fall
Patent expiries continue to hurt sales and earnings Read More >>

Tags: AstraZeneca, profits

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013